Good Morning -

The issue of banking of blood or other samples for possible genetic
testing has come up at many of our IRB meetings.  An increasing
number of companies conducting clinical trials are requesting
additional samples of blood from study subjects to be used for future
genetic testing that may or may not be related to the disease being
investigated.  In most cases the genetic samples remain anonymous.

Our IRB is concerned about this issue for at least two reasons.

1) What happens if the company uses the genetic samples in research
that leads to intellectual property, patents or inventions.

2) What are the patients rights with regard to finding out if the
results show a genetic pre-disposition to a disease.

If anyone has any information or knows of any OPRR communications
regarding this, I'd appreciate it.

Thanks.
----------------------------
Alexander Schoen
Office of Sponsored Programs
Winthrop University Hospital
259 First Street
Mineola, NY  11501
Phone: 516-663-4931
Fax    :  516-663-8590
e-mail: xxxxxx@winthrop.org

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================